Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by a progressive and irreversible decrease in lung function caused by thickening and damage to the air sac walls (called alveoli). Dry cough, gradual shortness of breath, nail clubbing, and fatigue are all common symptoms. Other symptoms include weight loss and muscle and joint pain. Other complications include hypertension, heart failure, pulmonary embolism, and pneumonia.
Acid reflux from the stomach, certain viruses such as Epstein-Barr virus and herpes virus, and environmental factors such as breathing in dust such as silica dust, asbestos fibers, hard metal dust, and coal dust are all major causes of lung damage. Idiopathic Pulmonary Fibrosis Treatment Market includes oxygen therapy, pulmonary rehabilitation, symptom management, and lung transplant.
